These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 22356331)

  • 1. Sense in antisense therapy for spinal muscular atrophy.
    MacKenzie A
    N Engl J Med; 2012 Feb; 366(8):761-3. PubMed ID: 22356331
    [No Abstract]   [Full Text] [Related]  

  • 2. Is RNA manipulation a viable therapy for spinal muscular atrophy?
    Horne C; Young PJ
    J Neurol Sci; 2009 Dec; 287(1-2):27-31. PubMed ID: 19758605
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Splicing-Correcting Therapy for SMA.
    Wan L; Dreyfuss G
    Cell; 2017 Jun; 170(1):5. PubMed ID: 28666123
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rescue of a severe mouse model for spinal muscular atrophy by U7 snRNA-mediated splicing modulation.
    Meyer K; Marquis J; Trüb J; Nlend Nlend R; Verp S; Ruepp MD; Imboden H; Barde I; Trono D; Schümperli D
    Hum Mol Genet; 2009 Feb; 18(3):546-55. PubMed ID: 19010792
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antisense oligonucleotides and spinal muscular atrophy: skipping along.
    Burghes AH; McGovern VL
    Genes Dev; 2010 Aug; 24(15):1574-9. PubMed ID: 20679391
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antisense oligonucleotides shed new light on the pathogenesis and treatment of spinal muscular atrophy.
    Yee JK; Lin RJ
    Mol Ther; 2012 Jan; 20(1):8-10. PubMed ID: 22215052
    [No Abstract]   [Full Text] [Related]  

  • 7. Therapeutics that directly increase SMN expression to treat spinal muscular atrophy.
    Shababi M; Mattis VB; Lorson CL
    Drug News Perspect; 2010 Oct; 23(8):475-82. PubMed ID: 21031163
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FDA Approval of Nusinersen for Spinal Muscular Atrophy Makes 2016 the Year of Splice Modulating Oligonucleotides.
    Aartsma-Rus A
    Nucleic Acid Ther; 2017 Apr; 27(2):67-69. PubMed ID: 28346110
    [No Abstract]   [Full Text] [Related]  

  • 9. Doxycycline-controlled splicing modulation by regulated antisense U7 snRNA expression cassettes.
    Marquis J; Kämpfer SS; Angehrn L; Schümperli D
    Gene Ther; 2009 Jan; 16(1):70-7. PubMed ID: 18701908
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trans-splicing, more than meets the eye: multifaceted therapeutics for spinal muscular atrophy.
    Butchbach ME
    Hum Gene Ther; 2011 Feb; 22(2):121-5. PubMed ID: 21288085
    [No Abstract]   [Full Text] [Related]  

  • 11. Neurodevelopmental consequences of Smn depletion in a mouse model of spinal muscular atrophy.
    Liu H; Shafey D; Moores JN; Kothary R
    J Neurosci Res; 2010 Jan; 88(1):111-22. PubMed ID: 19642194
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic therapy for spinal muscular atrophy.
    MacKenzie A
    Nat Biotechnol; 2010 Mar; 28(3):235-7. PubMed ID: 20212484
    [No Abstract]   [Full Text] [Related]  

  • 13. Spinal muscular atrophy: state-of-the-art and therapeutic perspectives.
    Wirth B
    Amyotroph Lateral Scler Other Motor Neuron Disord; 2002 Jun; 3(2):87-95. PubMed ID: 12215230
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antisense-based therapy for the treatment of spinal muscular atrophy.
    Rigo F; Hua Y; Krainer AR; Bennett CF
    J Cell Biol; 2012 Oct; 199(1):21-5. PubMed ID: 23027901
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antisense rescues babies from killer disease.
    Wadman M
    Science; 2016 Dec; 354(6318):1359-1360. PubMed ID: 27980162
    [No Abstract]   [Full Text] [Related]  

  • 16. Transplantation of gene-corrected motor neurons as a therapeutic strategy for spinal muscular atrophy.
    Meyer K; Miranda CJ; Kaspar BK
    Mol Ther; 2013 Mar; 21(3):502-3. PubMed ID: 23449105
    [No Abstract]   [Full Text] [Related]  

  • 17. Spinal muscular atrophy: from gene to therapy.
    Wirth B; Brichta L; Hahnen E
    Semin Pediatr Neurol; 2006 Jun; 13(2):121-31. PubMed ID: 17027862
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression profiling in spinal muscular atrophy reveals an RNA binding protein deficit.
    Anderson KN; Baban D; Oliver PL; Potter A; Davies KE
    Neuromuscul Disord; 2004 Nov; 14(11):711-22. PubMed ID: 15482955
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SAHA ameliorates the SMA phenotype in two mouse models for spinal muscular atrophy.
    Riessland M; Ackermann B; Förster A; Jakubik M; Hauke J; Garbes L; Fritzsche I; Mende Y; Blumcke I; Hahnen E; Wirth B
    Hum Mol Genet; 2010 Apr; 19(8):1492-506. PubMed ID: 20097677
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Romancing the spliceosome to fight spinal muscular atrophy.
    Swoboda KJ
    N Engl J Med; 2014 Oct; 371(18):1752-4. PubMed ID: 25354110
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.